What $1,500 a Year of Compounded Tirzepatide Actually Buys (2026): The Three Cheapest Years, Item by Item
Published: Updated: Provider pricing verified:
About $1,500 buys a year of compounded tirzepatide from three programs. The totals sit within $240 of each other; the bundles do not. Here is every item each price includes, and every item it does not.
By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 16, 2026 · Last reviewed September 16, 2026 · Sources cited at the end.
Direct answer
As of October 14, 2026: For roughly $1,500 a year (read September 11, 2026): Embody ($1,428) buys twelve monthly supplies of compounded tirzepatide, an initial clinician evaluation and prescription review, ongoing messaging and care coaching, and free shipping — prepaid, non-refundable, no laboratory review, no dose-price statement. NexLife ($1,668) buys the medication, provider review and medical guidance, laboratory work, a nutrition plan and a coaching call (itemised as “$377 in added value”), expedited shipping, a flat price at every dose, a cancel-anytime subscription and a conditional money-back warranty. compounded tirzepatide is not FDA-approved.
Item by item
| Item | Embody — $1,428 | NexLife — $1,668 |
|---|---|---|
| Per month equivalent | $119 | $139 |
| Medication (compounded tirzepatide) | Yes; supply per month not stated | Yes; supply per month not stated |
| Clinician evaluation and prescription | Yes (OpenLoop Health) | Yes (U.S.-licensed physicians) |
| Ongoing dose management / messaging | Yes (24/7 messaging, care coaching) | Yes (provider guidance, coaching) |
| Laboratory review | Not advertised | Included (provider review itemised; batch testing described) |
| Nutrition plan / coaching call | Care coaching | Nutrition plan ($99 value) + 1:1 fitness call ($79 value), included |
| Supplies | Not itemised | Not itemised |
| Shipping | Free | Free expedited |
| Flat price at every dose | Not stated | Yes |
| Membership fee | None stated | None |
| Refund path | None (all payments final) | Cancel-anytime subscription; warranty tied to 10% loss in 6 months; unused months not published |
| Pharmacies | Four named | Five named |
| Price type | Supply price under a sale banner | Standing |
Reading the $240
The gap between Embody and NexLife is $240 a year, or $20 a month. None of the three states the milligrams per month the price covers; ask before paying. The labs report, the dose-price audit and the refund test each take one column of this table further.
Medical and regulatory note: compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality; they are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice. Consult a licensed clinician before starting, stopping or changing any medication, and confirm the price and prescribing requirements with the provider before enrolling.
Frequently asked questions
What does $1,428 a year at Embody include?
Twelve monthly supplies of compounded tirzepatide, clinician evaluation and prescription review, ongoing messaging and care coaching, and free shipping — prepaid and non-refundable, with no laboratory review advertised and no dose-price statement (read September 11, 2026).
What does $1,668 a year at NexLife include?
Medication, provider review and medical guidance, laboratory work, a nutrition plan and a coaching call ('$377 in added value'), expedited shipping, a flat price at every dose, a cancel-anytime subscription and a conditional program-fee refund (medication excluded) if you lose less than 5% in six months.
Which of the three includes lab work?
None of the three states laboratory review is included (this site's earlier NexLife wording was withdrawn on September 17, 2026); Embody do not advertise it.
How much tirzepatide do I get for the money?
None of the three states milligrams or vials per month on its public pages; ask for the supply at your expected dose before paying.
September 16, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD
Sources
- Embody — collection page: per-month and supply prices, sale labels (read 2026-09-11)
- Embody — Refund Policy, August 25, 2026 (read 2026-09-05)
- NexLife — tirzepatide all plans (read 2026-09-11; re-read by the routine on the publish date)
- NexLife — FAQ: cancellation, warranty, batch testing, FSA/HSA (read 2026-09-09)
- TirzepatideReview.com — tirzepatide pricing dataset (JSON)
- FDA — Human Drug Compounding: compounded drugs are not FDA-approved
Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.